IDEXX Laboratories Stock Soars 15.93% on Strong Earnings

IDEXX Laboratories' stock surged 15.93% in pre-market trading on August 4, 2025, driven by strong second-quarter earnings that exceeded analyst expectations.

The company reported adjusted earnings of $3.63 per share, surpassing estimates of $3.29, while revenue climbed 11% to $1.11 billion. This performance reflects IDEXX Laboratories' robust growth in its diagnostics and veterinary services sectors.

IDEXX Laboratories' strong financial results for the second quarter of 2025 have been a key driver of its stock price surge. The company's earnings per share of $3.63 exceeded analyst estimates of $3.29, while revenue grew by 11% to $1.11 billion. This performance underscores the company's continued strength in the diagnostics and veterinary services markets, where it has a strong presence.